Reimund JM - Search Results

1

Severe ulcerative colitis: present medical treatment strategies.

Baudet A, Rahmi G, Bretagne AL, Gloro R, Justum AM, Reimund JM. Baudet A, et al. Among authors: reimund jm. Expert Opin Pharmacother. 2008 Feb;9(3):447-57. doi: 10.1517/14656566.9.3.447. Expert Opin Pharmacother. 2008. PMID: 18220494 Review.

2

Anti-tumor necrosis factor-alpha (TNF-alpha) treatment strategies in Crohn's disease.

Reimund JM, Ratajczyk J, Sola B, Justum AM, Muller CD. Reimund JM, et al. Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):21-34. doi: 10.2174/187221307779815093. Recent Pat Inflamm Allergy Drug Discov. 2007. PMID: 19075963 Review.

3

Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?

Gloro R, Ducrotte P, Reimund JM. Gloro R, et al. Among authors: reimund jm. Expert Opin Ther Targets. 2005 Oct;9(5):1079-95. doi: 10.1517/14728222.9.5.1079. Expert Opin Ther Targets. 2005. PMID: 16185159 Review.

4

[Nutritional therapy in inflammatory bowel disease].

Piquet MA, Gloro R, Justum AM, Reimund JM. Piquet MA, et al. Among authors: reimund jm. Gastroenterol Clin Biol. 2006 Feb;30(2):262-71. doi: 10.1016/s0399-8320(06)73163-3. Gastroenterol Clin Biol. 2006. PMID: 16565660 Free article. Review. French.

5

Enteral nutrition in adult Crohn's disease: present status and perspectives.

Dupont B, Dupont C, Justum AM, Piquet MA, Reimund JM. Dupont B, et al. Among authors: reimund jm. Mol Nutr Food Res. 2008 Aug;52(8):875-84. doi: 10.1002/mnfr.200800093. Mol Nutr Food Res. 2008. PMID: 18711759 Review.

6

Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions.

Leonetti D, Reimund JM, Tesse A, Viennot S, Martinez MC, Bretagne AL, Andriantsitohaina R. Leonetti D, et al. Among authors: reimund jm. PLoS One. 2013 Sep 3;8(9):e73088. doi: 10.1371/journal.pone.0073088. eCollection 2013. PLoS One. 2013. PMID: 24019899 Free PMC article.

7

[Treatment with cyclosporine of severe colitis in hemorrhagic rectocolitis. Apropos of 7 cases].

Reimund JM, Duclos B, Baumann R. Reimund JM, et al. Ann Med Interne (Paris). 1997;148(8):527-9. Ann Med Interne (Paris). 1997. PMID: 9538398 French.

8

Recent developments in colorectal cancer treatment by monoclonal antibodies.

Arsene D, Galais MP, Bouhier-Leporrier K, Reimund JM. Arsene D, et al. Among authors: reimund jm. Expert Opin Biol Ther. 2006 Nov;6(11):1175-92. doi: 10.1517/14712598.6.11.1175. Expert Opin Biol Ther. 2006. PMID: 17049015 Review.

9

Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.

Coëffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bôle-Feysot C, Déchelotte P, Reimund JM, Ducrotté P. Coëffier M, et al. Among authors: reimund jm. Am J Gastroenterol. 2010 May;105(5):1181-8. doi: 10.1038/ajg.2009.700. Epub 2009 Dec 8. Am J Gastroenterol. 2010. PMID: 19997094

10

[Practical forms for the use of the main drugs in the treatment of ulcerative colitis].

Lemann M, Beaugerie L, Bouhnik Y, Flourié B, Reimund JM, Seksik P, Marteau P. Lemann M, et al. Among authors: reimund jm. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 2):1039-48. doi: 10.1016/s0399-8320(04)95180-9. Gastroenterol Clin Biol. 2004. PMID: 15672574 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters